---
title: "Nourish's $100M Series C: Dietitian-Led Metabolic Health Hits $215M Total Funding"
description: "Nourish closed $100M Series C in NYC — the country's largest dietitian-led metabolic health clinic scales virtual care with real clinical outcomes."
date: 2026-05-21T00:00:00.000Z
tags: ["2026-vc-news", "nyc-vc-news", "startup-funding", "venture-capital", "healthtech", "nyc-startups"]
source: https://venturecapitaltracker.com/2026-nourish-100m-series-c-metabolic-health-nyc
---

# Nourish's $100M Series C: Dietitian-Led Metabolic Health Hits $215M Total Funding

> Nourish closed $100M Series C in NYC — the country's largest dietitian-led metabolic health clinic scales virtual care with real clinical outcomes.

Healthcare VCs spent a decade funding "Uber for pills." **Nourish raised $100M because clinicians actually show up.**

### The thesis in one sentence
Nourish runs what it calls the **country's largest dietitian-led metabolic health clinic** — virtual, outcomes-oriented, and built around licensed nutrition professionals rather than generic wellness content.

### Deal snapshot
- **Round:** $100M Series C (May 2026)  
- **Total funding:** $215M  
- **HQ:** New York  

### Why now
GLP-1 adoption, diabetes prevention budgets, and employer wellness spend are converging. Investors want **care models that payers and employers can credential** — not another meditation app.

### What good looks like for operators
- **Clinical outcomes** (A1C, weight, adherence) documented per cohort  
- **Payer and employer contracts** with clear ROI stories  
- **Dietitian utilization** as a capacity metric, not just MAU  

### Practical takeaway
NYC healthtech is rewarding **licensed-clinician-led models** at growth stage. If your stack can't survive an audit, this round isn't your comp — fix compliance first.

### Sources
1. VC News Daily: https://vcnewsdaily.com/

**By:** [Venture Capital Tracker](https://venturecapitaltracker.com/editorial-policy)

**Editorial note:** AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.